Shelby Knowles / Bloomberg via Getty Images Eli Lilly's Zepbound can be covered by Medicare Part D plans after the FDA approved the drug as a treatment for sleep apnea last month. Weight loss ...

Houston Texans wide receiver John Metchie absorbs hit-stick tackle during key third-down conversion before halftime. Houston Texans quarterback C.J. Stroud connects with wide receiver John Metchie ...

Severance season two premieres tomorrow (January 17) on Apple TV+ with episodes airing ... Unlike Mark S, Helly R, Irv (John Turturro) and the other employees of Lumon, she hasn’t retained ...

The FDA has approved Eli Lilly’s Omvoh (mirikizumab-mrkz ... This most recent approval for Crohn’s disease is based on positive results from the Phase III VIVID-1 clinical trial. 1 In a press release, ...

The issues surrounding the question of eligibility for Southern Miss basketball player John Wade III are confusing, even to those who generally know the rules. When Wade was recruited to play with ...

Shares of Eli Lilly have been falling in recent months, but that could spell opportunity. Investors appear to be concerned that a new government could impact its growth potential. The business is ...

Apple (AAPL) closed at $237.87 in the latest trading session, marking a +1.97% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 1.83%. Meanwhile, the Dow ...

SAN FRANCISCO — When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously sold in injectable pens, it framed the move as a way ...

What will Eli Lilly do with all its cash from Mounjaro and Zepbound? What does CEO Dave Ricks think it would take for the company to reach a $1 trillion market capitalization? And how does Ricks ...

Houston Texans quarterback C.J. Stroud connects with wide receiver John Metchie for a 24-yard gain against the Kansas City Chiefs with two minutes left in the first half. Houston Texans ...

according to the final results of the Phase III KATHERINE clinical trial led by researchers from the University of Pittsburgh and UPMC Hillman Cancer Center. "KATHERINE is a landmark clinical ...

Eli Lilly (NYSE: LLY) saw its stock decline sharply by 6.5% on January 14, following the release of its fourth-quarter 2024 revenue guidance, which fell short of Wall Street expectations. The ...